TransEnterix (NYSEMKT:TRXC) has witnessed a drop of 8.1% or 537,480 shares in its short figure. The short interest diminution took it from 6,619,269 on May 31,2016 to 6,081,789 on June 15,2016. In terms of floated shares, the short interest was calculated to be 10.4%. The days to cover are 7 given that the daily volume averaged 886,669 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
TransEnterix (NYSEMKT:TRXC): The stock opened at $1.29 on Friday but the bulls could not build on the opening and the stock topped out at $1.35 for the day. The stock traded down to $1.28 during the day, due to lack of any buying support eventually closed down at $1.30 with a loss of -6.47% for the day. The stock had closed at $1.39 on the previous day. The total traded volume was 2,217,545 shares.
The company shares have dropped -53.07% from its 1 Year high price. On Apr 6, 2016, the shares registered one year high at $6.10 and the one year low was seen on Jun 24, 2016. The 50-Day Moving Average price is $1.70 and the 200 Day Moving Average price is recorded at $2.83.
TransEnterix (NYSEMKT:TRXC) has tumbled 5.8% during the past week and has dropped 30.48% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 4.23%. TransEnterix (NYSEMKT:TRXC) has underperformed the index by 28.38% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.